Thyroxine / Triiodothyronine Oral Tablet

Brand(s)
Thyrolar
Category(s)
prescription
SPL Type(s)
Human Prescription
Master SPL
Forest Laboratories, Inc (2013-01-15)
Oldest Current Product
1969-11-21
License(s)
NDA
RxNORM
ORAL TABLET\THYROXINE:TRIIODOTHYRONINE
FDAOB
ORAL\TABLET\LIOTRIX (T4: T3)
SPL Active
ORAL\TABLET\LEVOTHYROXINE SODIUM: LIOTHYRONINE SODIUM
SPL Moiety
ORAL\TABLET\LEVOTHYROXINE: LIOTHYRONINE

product(s) by strength(s)

levothyroxine sodium 0.0125 mg / liothyronine sodium 0.0031 mg oral tablet

original product(s)(s)

#idbrandcategorylabelerfirst marketedactive ingredient(s)routedose formapplicationspl
1004560040ThyrolarNDAForest Laboratories, Inc1969-11-21LEVOTHYROXINE SODIUM, LIOTHYRONINE SODIUMORALTABLETNDA0168077d028b83-5166-4b2e-b442-ba6cbfefbfd6

levothyroxine sodium 0.025 mg / liothyronine sodium 0.00625 mg oral tablet

original product(s)(s)

#idbrandcategorylabelerfirst marketedactive ingredient(s)routedose formapplicationspl
1004560045ThyrolarNDAForest Laboratories, Inc1969-11-21LEVOTHYROXINE SODIUM, LIOTHYRONINE SODIUMORALTABLETNDA0168077d028b83-5166-4b2e-b442-ba6cbfefbfd6

levothyroxine sodium 0.05 mg / liothyronine sodium 0.0125 mg oral tablet

original product(s)(s)

#idbrandcategorylabelerfirst marketedactive ingredient(s)routedose formapplicationspl
1004560050ThyrolarNDAForest Laboratories, Inc1969-11-21LEVOTHYROXINE SODIUM, LIOTHYRONINE SODIUMORALTABLETNDA0168077d028b83-5166-4b2e-b442-ba6cbfefbfd6

levothyroxine sodium 0.1 mg / liothyronine sodium 0.025 mg oral tablet

original product(s)(s)

#idbrandcategorylabelerfirst marketedactive ingredient(s)routedose formapplicationspl
1004560055ThyrolarNDAForest Laboratories, Inc1969-11-21LEVOTHYROXINE SODIUM, LIOTHYRONINE SODIUMORALTABLETNDA0168077d028b83-5166-4b2e-b442-ba6cbfefbfd6

levothyroxine sodium 0.15 mg / liothyronine sodium 0.0375 mg oral tablet

original product(s)(s)

#idbrandcategorylabelerfirst marketedactive ingredient(s)routedose formapplicationspl
1004560060ThyrolarNDAForest Laboratories, Inc1969-11-21LEVOTHYROXINE SODIUM, LIOTHYRONINE SODIUMORALTABLETNDA0168077d028b83-5166-4b2e-b442-ba6cbfefbfd6

application(s)

#idtitledeprecatedapplicantapproved drug
1NDA016680EUTHROID-0.5TruePARKE DAVIS DIV WARNER LAMBERT CONDA016680_001, NDA016680_002, NDA016680_003, NDA016680_004
2NDA016807THYROLAR-0.25FOREST LABORATORIES INCNDA016807_001, NDA016807_002, NDA016807_003, NDA016807_004, NDA016807_005, NDA016807_006

application drug(s)

#idcategory/deprecatedingredient strength(s)routedose formrldapplication
1NDA016680_001discontinuedT3) (0.0075MG), LIOTRIX (T4 (0.03MG)ORALTABLETFalseEUTHROID-0.5
2NDA016680_002discontinuedLIOTRIX (T4 (0.06MG), T3) (0.015MG)ORALTABLETFalseEUTHROID-0.5
3NDA016680_003discontinuedLIOTRIX (T4 (0.12MG), T3) (0.03MG)ORALTABLETFalseEUTHROID-0.5
4NDA016680_004discontinuedT3) (0.045MG), LIOTRIX (T4 (0.18MG)ORALTABLETFalseEUTHROID-0.5
5NDA016807_001RXLIOTRIX (T4 (0.0125MG), T3) (0.0031MG)ORALTABLETFalseTHYROLAR-0.25
6NDA016807_002RXT3) (0.025MG), LIOTRIX (T4 (0.1MG)ORALTABLETFalseTHYROLAR-0.25
7NDA016807_003RXLIOTRIX (T4 (0.15MG), T3) (0.0375MG)ORALTABLETTrueTHYROLAR-0.25
8NDA016807_004RXLIOTRIX (T4 (0.05MG), T3) (0.0125MG)ORALTABLETFalseTHYROLAR-0.25
9NDA016807_005RXT3) (0.0063MG), LIOTRIX (T4 (0.025MG)ORALTABLETFalseTHYROLAR-0.25
10NDA016807_006discontinuedT3) (0.0625MG), LIOTRIX (T4 (0.25MG)ORALTABLETFalseTHYROLAR-0.25

spl(s)

#idtitlecategorytypelabelerlabeler actlast updateversionproduct(s)
17d028b83-5166-4b2e-b442-ba6cbfefbfd6 (view SPL)Thyrolar Tablets(Liotrix Tablets, USP)prescriptionHuman PrescriptionForest Laboratories, IncMANUFACTURE2013-01-154004560040, 004560045, 004560050, 004560055, 004560060

Data from: FDAOB, FDAPB, LOINC, MTHSPL, NDFRT, NCIT, RxNORM, UNII